Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
and greater percentages of participants achieving an A1C less than 5.7 percent for tirzepatide 10 mg and 15 mg compared to semaglutide
Those using GLP-1 medications solely for weight management (without diabetes) are not at risk for diabetic retinopathy progression, though they should report any visual symptoms promptly given the ongoing investigation of rare non-retinopathy eye events
Meanwhile, agilons stock was down 13% on the week as it continues to struggle with its capitated book of lives, viewing 2025 as a transition year for the business
10.1016/S0140-6736(10)60484-9 8
US$ 27.61
US$ 22.49
US$ 23.75
US$ 29.20
